Marks Group Wealth Management, Inc Atri Cure, Inc. Transaction History
Marks Group Wealth Management, Inc
- $1.02 Billion
- Q2 2025
A detailed history of Marks Group Wealth Management, Inc transactions in Atri Cure, Inc. stock. As of the latest transaction made, Marks Group Wealth Management, Inc holds 28,973 shares of ATRC stock, worth $850,937. This represents 0.09% of its overall portfolio holdings.
Number of Shares
28,973
Previous 21,185
36.76%
Holding current value
$850,937
Previous $683,000
38.95%
% of portfolio
0.09%
Previous 0.07%
Shares
5 transactions
Others Institutions Holding ATRC
# of Institutions
238Shares Held
51.9MCall Options Held
32.6KPut Options Held
4.5K-
Vanguard Group Inc Valley Forge, PA4.71MShares$138 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$136 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.68MShares$108 Million0.05% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL3MShares$88.1 Million1.84% of portfolio
-
Macquarie Group LTD Australia, C32.44MShares$71.6 Million0.1% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.36B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...